Bicara Therapeutics BCAX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's operating lease liabilities (current)?
- Bicara Therapeutics (BCAX) reported operating lease liabilities (current) of $1.14M in Q1 2026.
- How has Bicara Therapeutics's operating lease liabilities (current) changed year-over-year?
- Bicara Therapeutics's operating lease liabilities (current) increased by 92.9% year-over-year, from $591K to $1.14M.
- What is the long-term trend for Bicara Therapeutics's operating lease liabilities (current)?
- Over 2 years (2023 to 2025), Bicara Therapeutics's operating lease liabilities (current) has grown at a 98.0% compound annual growth rate (CAGR), from $285K to $1.12M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.